MINCI STENSON, DR.
Inpatient Obstetric Registered Nurse in BEVERLY HILLS, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MINCI STENSON, DR. filed 355 Medicare Part D claims in 2023 as a Inpatient Obstetric Registered Nurse in BEVERLY HILLS, California, prescribing 91% generic.
- 355
- Part D claims, 2023
- 91%
- generic prescribing
- $634.43
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MINCI STENSON, DR.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
355 Top 43% higher than 57% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about MINCI STENSON, DR.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in California
How Inpatient Obstetric Registered Nurse compares to other specialties among California providers
Inpatient Obstetric Registered Nurse share within California
Inpatient Obstetric Registered Nurse is one of the more visible NUCC categories in California
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Inpatient Obstetric Registered Nurse (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Inpatient Obstetric Registered Nurse ABMS/AOA estimate
Est. board-certified rate (Inpatient Obstetric Registered Nurse) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Inpatient Obstetric Registered Nurse US NPIs
Specialty board-certified rate — Inpatient Obstetric Registered Nurse estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MINCI STENSON, DR. appears in the CMS NPPES registry as a Inpatient Obstetric Registered Nurse provider holding DR. credentials at 8484 WILSHIRE BLVD STE 200, BEVERLY HILLS, CA, 90211, with a listed phone of (310) 360-7690. NPI 1083378343 was issued on 10/23/2021. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what STENSON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 355 prescription claims written by this provider, covering 38 Medicare beneficiaries and totaling roughly $55K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Inpatient Obstetric Registered Nurse is a narrow specialty nationwide, with 566 enrolled providers across 52 states and an average of 705 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1083378343 |
|---|---|
| Specialty | Inpatient Obstetric Registered Nurse |
| Credentials | DR. |
| Gender | Female |
| NPI Issued | 10/23/2021 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MINCI STENSON, DR.'s current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MINCI STENSON, DR.. Source: openpaymentsdata.cms.gov.
Total received
$634
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — California MBC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MINCI STENSON, DR.. To verify MINCI STENSON, DR.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
9% brand-name claims vs 91% generic, on 355 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 433
- Total Day Supply
- 12,890
- Brand vs Generic
- 9% brand / 91% generic
- Brand Drug Cost
- $45K
- Generic Drug Cost
- $9K
Patient Demographics
- Average Patient Age
- 61.9 years
- Avg HCC Risk Score
- 1.33
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 21, 65-74: 13, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MINCI STENSON, DR. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Fluoxetine Hcl
Fluoxetine Hcl
44 claims
- Sertraline Hcl
Sertraline Hcl
40 claims
- Trazodone Hcl
Trazodone Hcl
35 claims
- Lorazepam
Lorazepam
23 claims
- Gabapentin
Gabapentin
22 claims
- Vraylar 17
Vraylar
17 claims
- Alprazolam 14
Alprazolam
14 claims
- Quetiapine Fumarate 14
Quetiapine Fumarate
14 claims
| Drug | Claims |
|---|---|
| Fluoxetine Hcl | 44 |
| Sertraline Hcl | 40 |
| Trazodone Hcl | 35 |
| Lorazepam | 23 |
| Gabapentin | 22 |
| Vraylar Cariprazine Hcl | 17 |
| Alprazolam | 14 |
| Quetiapine Fumarate | 14 |
| Lithium Carbonate | 13 |
| Diazepam | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Inpatient Obstetric Registered Nurse Overview
How MINCI STENSON, DR. fits within the Inpatient Obstetric Registered Nurse landscape nationally.
MINCI STENSON, DR.'s 355 claims are below the specialty average of 705.
Nearby Inpatient Obstetric Registered Nurse Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as STENSON.
Compare Inpatient Obstetric Registered Nurse nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is MINCI STENSON, DR.'s specialty? ▼
How much does MINCI STENSON, DR. prescribe under Medicare Part D? ▼
Where is MINCI STENSON, DR. located? ▼
What is MINCI STENSON, DR.'s NPI number? ▼
Does MINCI STENSON, DR. prescribe more brand-name or generic drugs? ▼
How many Inpatient Obstetric Registered Nurse providers are there in the US? ▼
What drugs does MINCI STENSON, DR. prescribe most often? ▼
Does MINCI STENSON, DR. accept Medicare? ▼
How can I verify MINCI STENSON, DR.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology